BIO-GATE AG (BIG1.DE) Stock Price, Quote, News and Overview
FRA:BIG1 - Deutsche Boerse Ag - DE000BGAG981 - Common Stock - Currency: EUR
BIG1.DE Quote, Performance and Key Statistics
FRA:BIG1 (3/6/2025, 7:00:00 PM)
0.77
+0.03 (+3.36%)
The current stock price of BIG1.DE is 0.77 EUR. In the past month the price increased by 4.05%. In the past year, price decreased by -28.7%.
BIG1.DE Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 6D81.DE | DUPONT DE NEMOURS INC | 19.09 | 29.92B | ||
| DSFIR.AS | DSM-FIRMENICH AG | 10.51 | 25.51B | ||
| BRG.OL | BORREGAARD ASA | 21.84 | 18.00B | ||
| ELK.OL | ELKEM ASA | 29.74 | 14.84B | ||
| SY1.DE | SYMRISE AG | 34.09 | 13.39B | ||
| 1COV.DE | COVESTRO AG | N/A | 11.08B | ||
| AKZA.AS | AKZO NOBEL N.V. | 15.78 | 10.49B | ||
| EVK.DE | EVONIK INDUSTRIES AG | 27.39 | 10.08B | ||
| AMC.DE | ALBEMARLE CORP | N/A | 8.33B | ||
| SYENS.BR | SYENSQO SA | N/A | 7.47B | ||
| AKE.PA | ARKEMA | 10.06 | 6.30B | ||
| WCH.DE | WACKER CHEMIE AG | 30.92 | 4.02B |
Related stock screener links
About BIG1.DE
Company Profile
Bio-Gate AG engages in the development and production of technologies and solutions for health and hygiene, primarily used in orthopedics, traumatology, and vascular surgery. The company is headquartered in Nuremberg, Bayern and currently employs 45 full-time employees. The company went IPO on 2006-04-05. The firm employs silver technology to endow materials and products with antimicrobial properties, and specializes in plasmacoating, spray, additives and textile solutions, among others. The company produces medical technology products, as well as technologies to refine cosmetics, consumer goods and industrial products. Its products are applied in the area of implants, skin care, cosmetics, orthopedics, industrial applications, consumer goods, would care, textiles and dental products. The firm incorporates silver particles into cosmetics, paints, veneers or plastics, or involves coating of final products, such as implants or wound dressings, with a silver-containing functional layer.
Company Info
BIO-GATE AG
Neumeyerstrasse 28-34
Nuremberg BAYERN DE
Employees: 45
Company Website: https://www.bio-gate.de/
Investor Relations: http://www.bio-gate.de/unternehmen/
Phone: 49911477523100
BIO-GATE AG / BIG1.DE FAQ
What is the stock price of BIO-GATE AG today?
The current stock price of BIG1.DE is 0.77 EUR. The price increased by 3.36% in the last trading session.
What is the ticker symbol for BIO-GATE AG stock?
The exchange symbol of BIO-GATE AG is BIG1 and it is listed on the Deutsche Boerse Ag exchange.
On which exchange is BIG1.DE stock listed?
BIG1.DE stock is listed on the Deutsche Boerse Ag exchange.
What is the price forecast or stock price prediction for BIO-GATE AG stock?
8 analysts have analysed BIG1.DE and the average price target is 3.37 EUR. This implies a price increase of 337.14% is expected in the next year compared to the current price of 0.77. Check the BIO-GATE AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is BIO-GATE AG worth?
BIO-GATE AG (BIG1.DE) has a market capitalization of 7.11M EUR. This makes BIG1.DE a Nano Cap stock.
How many employees does BIO-GATE AG have?
BIO-GATE AG (BIG1.DE) currently has 45 employees.
What are the support and resistance levels for BIO-GATE AG (BIG1.DE) stock?
BIO-GATE AG (BIG1.DE) has a support level at 0.76 and a resistance level at 0.78. Check the full technical report for a detailed analysis of BIG1.DE support and resistance levels.
Is BIO-GATE AG (BIG1.DE) expected to grow?
The Revenue of BIO-GATE AG (BIG1.DE) is expected to grow by 4.65% in the next year. Check the estimates tab for more information on the BIG1.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy BIO-GATE AG (BIG1.DE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BIG1.DE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BIG1.DE, evaluating the profitability, health, valuation and growth aspects
- BIO-GATE AG (BIG1.DE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BIO-GATE AG (BIG1.DE) Sales and EPS estimates to see what analysts future expectations are.
- BIO-GATE AG (BIG1.DE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BIO-GATE AG (BIG1.DE) Insider and Institutional Ownership to learn about the owners and their transactions.
- BIO-GATE AG (BIG1.DE) Stock Chart to make your own analysis
- BIO-GATE AG (BIG1.DE) Latest news and press-releases to stay up to date.
Does BIO-GATE AG (BIG1.DE) stock pay dividends?
BIG1.DE does not pay a dividend.
What is the Price/Earnings (PE) ratio of BIO-GATE AG (BIG1.DE)?
BIO-GATE AG (BIG1.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.22).
BIG1.DE Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to BIG1.DE. When comparing the yearly performance of all stocks, BIG1.DE is a bad performer in the overall market: 87.66% of all stocks are doing better.
BIG1.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to BIG1.DE. The financial health of BIG1.DE is average, but there are quite some concerns on its profitability.
BIG1.DE Financial Highlights
Over the last trailing twelve months BIG1.DE reported a non-GAAP Earnings per Share(EPS) of -0.22. The EPS decreased by -33.87% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -45.48% | ||
| ROE | -87.45% | ||
| Debt/Equity | 0 |
BIG1.DE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to BIG1.DE. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of -37.5% and a revenue growth 4.65% for BIG1.DE